Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Up 7.5% in October

Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,990,000 shares, an increase of 7.5% from the October 15th total of 5,570,000 shares. Based on an average daily trading volume, of 1,480,000 shares, the short-interest ratio is currently 4.0 days.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Barclays dropped their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $86.67.

View Our Latest Report on Acadia Healthcare

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Blue Trust Inc. increased its stake in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $59,000. Covestor Ltd increased its holdings in shares of Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare in the third quarter valued at $86,000.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $37.82 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business’s fifty day moving average price is $58.05 and its two-hundred day moving average price is $65.55. The stock has a market cap of $3.51 billion, a PE ratio of 12.40, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33. Acadia Healthcare has a one year low of $37.78 and a one year high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the company earned $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Read More

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.